FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)-MedSci.cn

FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)

Vogel, A; Sahai, V; Hollebecque, A; Vaccaro, G; Melisi, D; Al-Rajabi, R; Paulson, AS; Borad, MJ; Gallinson, D; Murphy, AG; Oh, DY; Dotan, E; Catenacci, DV; Van Cutsem, E; Lihou, CF; Zhen, H; Feliz, L; Abou-Alfa, GK

ANNALS OF ONCOLOGY, 2019; 30 (): 876

科室
- - 订阅+
  - 更多科室
工具
服务